Matches in Wikidata for { <http://www.wikidata.org/entity/Q58495567> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- Q58495567 description "article scientifique publié en 2014" @default.
- Q58495567 description "artículu científicu espublizáu en xineru de 2014" @default.
- Q58495567 description "im Januar 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58495567 description "scientific article published on 31 January 2014" @default.
- Q58495567 description "wetenschappelijk artikel" @default.
- Q58495567 description "наукова стаття, опублікована в серпні 2014" @default.
- Q58495567 name "Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment" @default.
- Q58495567 name "Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment" @default.
- Q58495567 type Item @default.
- Q58495567 label "Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment" @default.
- Q58495567 label "Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment" @default.
- Q58495567 prefLabel "Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment" @default.
- Q58495567 prefLabel "Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment" @default.
- Q58495567 P1433 Q58495567-28DC0210-2726-4D5D-8840-0A49109D93A4 @default.
- Q58495567 P1476 Q58495567-2FFD0F73-BE25-4D3A-80E7-801EA453FA6B @default.
- Q58495567 P2093 Q58495567-04899468-C6C6-4E75-81C7-45C877B91A86 @default.
- Q58495567 P2093 Q58495567-451D8811-7BEB-418F-A1C3-2367F8C305FA @default.
- Q58495567 P2093 Q58495567-5C221A02-51A6-4B31-8A90-41FDC2F0DBE5 @default.
- Q58495567 P2093 Q58495567-61F97969-DBCC-4B5F-BB51-B1136D29349D @default.
- Q58495567 P2093 Q58495567-7F399C7B-5BE1-44CB-9C87-8B5BD2B8BC46 @default.
- Q58495567 P2093 Q58495567-9D6226DC-B072-4442-8788-663EB5F7A23F @default.
- Q58495567 P2093 Q58495567-CED97864-6FEC-4B39-B68F-8E2B339636FE @default.
- Q58495567 P2860 Q58495567-01853177-EF20-43AB-8C37-8499CE0F3065 @default.
- Q58495567 P2860 Q58495567-1C68746E-2219-4683-838F-D580D0056995 @default.
- Q58495567 P2860 Q58495567-28CE3A94-988D-422A-8406-291C9A1A0AB5 @default.
- Q58495567 P2860 Q58495567-2D84598D-C649-410E-BAC9-42B3B7BDAB12 @default.
- Q58495567 P2860 Q58495567-4348E6FF-7683-4023-B2BF-656381D8124E @default.
- Q58495567 P2860 Q58495567-4929198F-4A3B-4EF0-905E-EF5F9CCB966D @default.
- Q58495567 P2860 Q58495567-5F54F38E-7A4C-4A8E-A221-E2511651D4E1 @default.
- Q58495567 P2860 Q58495567-679AA8E8-C44E-4F5F-B48F-9B700FCAD19B @default.
- Q58495567 P2860 Q58495567-68F09B4D-D710-445E-9742-4D8CFD14B113 @default.
- Q58495567 P2860 Q58495567-A0B4FB03-7B6C-4C8A-9621-2A104DB3904B @default.
- Q58495567 P2860 Q58495567-A8FB05C9-AA23-4D99-88A3-C2D026A6AD9E @default.
- Q58495567 P2860 Q58495567-E5AEC630-35AC-4730-A4C0-753EF5B4FE05 @default.
- Q58495567 P2860 Q58495567-FE2E320D-F1C3-4551-9FCB-6BC532E25C18 @default.
- Q58495567 P304 Q58495567-F48E1D91-5B8D-408B-A68E-BB588DB2CE18 @default.
- Q58495567 P31 Q58495567-F2257A52-1D60-4376-85F2-A6F314D1DAF4 @default.
- Q58495567 P356 Q58495567-40C8D18C-4F3A-4E3B-AEA5-5EBEE21FDD31 @default.
- Q58495567 P433 Q58495567-3E1A3A85-EC8C-45C9-9D63-502720A8A4A9 @default.
- Q58495567 P478 Q58495567-6DA4A317-23C9-47AF-85D2-57C0F3967B18 @default.
- Q58495567 P50 Q58495567-CFA5C2BE-1B55-4638-A507-6BA6A15F0FD4 @default.
- Q58495567 P577 Q58495567-D8C8325C-E89C-452F-9456-15EC45DF7F61 @default.
- Q58495567 P698 Q58495567-1A0215C0-3C94-45D2-B1E9-99BFD90D9013 @default.
- Q58495567 P921 Q58495567-3ADC6D0E-BD13-4AFB-9768-D3C609B940F1 @default.
- Q58495567 P356 J.CROHNS.2014.01.009 @default.
- Q58495567 P698 24486178 @default.
- Q58495567 P1433 Q15817379 @default.
- Q58495567 P1476 "Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment" @default.
- Q58495567 P2093 "Ann-Charlotte Wikström" @default.
- Q58495567 P2093 "Laura Landucci" @default.
- Q58495567 P2093 "Loa Davidsdottir" @default.
- Q58495567 P2093 "Michael Eberhardson" @default.
- Q58495567 P2093 "Per Marits" @default.
- Q58495567 P2093 "Ragnar Befrits" @default.
- Q58495567 P2093 "Ulf Sundin" @default.
- Q58495567 P2860 Q28202504 @default.
- Q58495567 P2860 Q28246982 @default.
- Q58495567 P2860 Q28285876 @default.
- Q58495567 P2860 Q37862584 @default.
- Q58495567 P2860 Q37948705 @default.
- Q58495567 P2860 Q37987352 @default.
- Q58495567 P2860 Q38059422 @default.
- Q58495567 P2860 Q46464122 @default.
- Q58495567 P2860 Q47271726 @default.
- Q58495567 P2860 Q53002503 @default.
- Q58495567 P2860 Q57265316 @default.
- Q58495567 P2860 Q57265459 @default.
- Q58495567 P2860 Q58814220 @default.
- Q58495567 P304 "881-889" @default.
- Q58495567 P31 Q13442814 @default.
- Q58495567 P356 "10.1016/J.CROHNS.2014.01.009" @default.
- Q58495567 P433 "8" @default.
- Q58495567 P478 "8" @default.
- Q58495567 P50 Q55207977 @default.
- Q58495567 P577 "2014-01-31T00:00:00Z" @default.
- Q58495567 P698 "24486178" @default.
- Q58495567 P921 Q79460 @default.